Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 706 AL 720

L-Dopa and Brain Serotonin System Dysfunction

Stansley BJ, Yamamoto BK.

Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075.

[Genetic factors associated with dementia in Parkinson's disease (PD)]

Romo-Gutiérrez D, Yescas P, López-López M, Boll MC.

Gac Med Mex. 2015 Jan-Feb;151(1):110-8.

Effect of α-synuclein on membrane permeability and synaptic transmission: a clue to neurodegeneration?

Surguchev A, Surguchov A.

J Neurochem. 2015 Mar;132(6):619-21. doi: 10.1111/jnc.13045. Epub 2015 Mar 4.

Amyloid PET imaging: applications beyond Alzheimer's disease

Catafau AM, Bullich S.

Clin Transl Imaging. 2015;3(1):39-55. doi: 10.1007/s40336-014-0098-3. Epub 2015 Jan 21.

Effects of Treadmill Training with Load on Gait in Parkinson Disease: A Randomized Controlled Clinical Trial

Trigueiro LC, Gama GL, Simão CR, Sousa AV, Godeiro Júnior Cde O, Lindquist AR.

Am J Phys Med Rehabil. 2015 Oct;94(10 Suppl 1):830-7. doi: 10.1097/PHM.0000000000000249.

Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases

Dagda RK, Das Banerjee T.

Rev Neurosci. 2015;26(3):359-70. doi: 10.1515/revneuro-2014-0085.

Exercise and medication effects on persons with Parkinson disease across the domains of disability: a randomized clinical trial

Dibble LE, Foreman KB, Addison O, Marcus RL, LaStayo PC.

J Neurol Phys Ther. 2015 Apr;39(2):85-92. doi: 10.1097/NPT.0000000000000086.

Piribedil and pathological gambling in six parkinsonian patients

Micheli FE, Giugni JC, Espinosa ME, Calvo DS, Raina GB.

Arq Neuropsiquiatr. 2015 Feb;73(2):115-8. doi: 10.1590/0004-282X20140212.

The contribution of mitochondria to sensory processing and pain

Flatters SJ.

Prog Mol Biol Transl Sci. 2015;131:119-46. doi: 10.1016/bs.pmbts.2014.12.004. Epub 2015 Feb 7.

[A case of an anti-Ma2 antibody-positive patient presenting with variable CNS symptoms mimicking multiple system atrophy with a partial response to immunotherapy]

Shiraishi W, Iwanaga Y, Yamamoto A.

Rinsho Shinkeigaku. 2015;55(2):96-100. doi: 10.5692/clinicalneurol.55.96.

Regenerative medicine for Parkinson's disease

Yasuhara T, Kameda M, Agari T, Date I.

Neurol Med Chir (Tokyo). 2015;55(2):113-23. doi: 10.2176/nmc.ra.2014-0264. Epub 2015 Jan 23.

Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism

Cannella M, Motolese M, Bucci D, Molinaro G, Gradini R, Bruno V, Nicoletti F, Battaglia G.

Neuropharmacology. 2015 Aug;95:50-8. doi: 10.1016/j.neuropharm.2015.02.024. Epub 2015 Mar 5.

Epidemiology of mild traumatic brain injury and neurodegenerative disease

Gardner RC, Yaffe K.

Mol Cell Neurosci. 2015 May;66(Pt B):75-80. doi: 10.1016/j.mcn.2015.03.001. Epub 2015 Mar 5.

Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist

Iderberg H, Maslava N, Thompson AD, Bubser M, Niswender CM, Hopkins CR, Lindsley CW, Conn PJ, Jones CK, Cenci MA.

Neuropharmacology. 2015 Aug;95:121-9. doi: 10.1016/j.neuropharm.2015.02.023. Epub 2015 Mar 4.

Therapeutic potential of berberine against neurodegenerative diseases

Jiang W, Li S, Li X.

Sci China Life Sci. 2015 Jun;58(6):564-9. doi: 10.1007/s11427-015-4829-0. Epub 2015 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias